HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Phthalates

This article was originally published in The Rose Sheet

Executive Summary

CIR will gather new and unpublished data on dibutyl phthalates to decide if re-review is necessary following new data from the National Center for Environmental Health suggesting phthalate exposure is higher and more common than expected, Cosmetic Ingredient Review Director Alan Andersen announces at expert panel meeting in Arlington, Va. Dec. 4-5. National Institute of Environmental Health Sciences and Centers For Disease Control & Prevention will conduct further studies on phthalates exposure in humans and sources of exposure, but not carcinogenicity potential as reported in "The Rose Sheet" Oct. 23, p. 8 and Dec. 4, p. 3

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008748

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel